While Inmode Ltd has underperformed by -2.69%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, INMD fell by -32.88%, with highs and lows ranging from $48.25 to $18.57, whereas the simple moving average fell by -27.24% in the last 200 days.
On November 03, 2023, UBS Downgraded Inmode Ltd (NASDAQ: INMD) to Neutral. A report published by Canaccord Genuity on October 13, 2023, Downgraded its rating to ‘Hold’ for INMD. UBS also rated INMD shares as ‘Buy’, setting a target price of $40 on the company’s shares in an initiating report dated March 29, 2023. Barclays initiated its ‘Overweight’ rating for INMD, as published in its report on December 21, 2022. Jefferies’s report from October 12, 2022 suggests a price prediction of $40 for INMD shares, giving the stock a ‘Buy’ rating. Barclays also rated the stock as ‘Overweight’.
Analysis of Inmode Ltd (INMD)
Further, the quarter-over-quarter decrease in sales is -5.08%, showing a negative trend in the upcoming months.
In order to gain a clear picture of Inmode Ltd’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 29.50% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 12.29, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.57M can be a very valuable indicator of volatility for INMD stock. On a monthly basis, the volatility of the stock is set at 3.92%, whereas on a weekly basis, it is put at 3.92%, with a loss of -5.91% over the past seven days. Furthermore, long-term investors anticipate a median target price of $28.40, showing growth from the present price of $21.33, which can serve as yet another indication of whether INMD is worth investing in or should be passed over.
How Do You Analyze Inmode Ltd Shares?
The Israel based company Inmode Ltd (INMD) is one of the biggest names in Medical Devices. When comparing Inmode Ltd shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 9.24, there is a growth in quarterly earnings of 47.17%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 9.73%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 65.84% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
INMD shares are owned by institutional investors to the tune of 65.84% at present.
